Information  X 
Enter a valid email address

Leeds Building Soc (LBS)

  Print      Mail a friend

Friday 13 December, 2019

Leeds Building Soc

Publication of a Prospectus

RNS Number : 8901W
Leeds Building Society
13 December 2019
 

RNS Number: 8901W

Leeds Building Society

 

Publication of Prospectus dated 13 December 2019

 

The following document has been approved by the Financial Conduct Authority on 13 December 2019 and is available for viewing:

 

PROSPECTUS DATED 13 DECEMBER 2019

Leeds Building Society

£2,000,000,000

Euro Medium Term Note Programme

 

To view the full document, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/8901W_1-2019-12-13.pdf

 

A copy of the Prospectus has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.leedsbuildingsociety.co.uk

 

For further information, please contact:

 

Leeds Building Society

105 Albion Street, Leeds LS1 5AS

Telephone: 0113 225 7527

 

Email: [email protected]

Website: www.leedsbuildingsociety.co.uk

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PDIQXLFFKLFXFBF

a d v e r t i s e m e n t